Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Frenkel

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
The Journal of Infectious Diseases|March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 CollaboratorsW Borkowsky, D Wara, T Fenton, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected childrenM Mirochnick, E Cooper, K McIntosh, et al.
The Journal of Infectious Diseases|October 27, 2001
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineE J McFarland, W Borkowsky, T Fenton, et al.
Pediatrics|August 3, 2001
Natural history of neonatal herpes simplex virus infections in the acyclovir eraD W Kimberlin, C Y Lin, R F Jacobs, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Science (New York, N.Y.)|June 6, 1998
Genetic evaluation of suspected cases of transient HIV-1 infection of infantsL M Frenkel, J I Mullins, G H Learn, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
The Journal of Infectious Diseases|March 18, 2000
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 CollaboratorsW Borkowsky, D Wara, T Fenton, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected childrenM Mirochnick, E Cooper, K McIntosh, et al.
The Journal of Infectious Diseases|October 27, 2001
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccineE J McFarland, W Borkowsky, T Fenton, et al.
Pediatrics|August 3, 2001
Natural history of neonatal herpes simplex virus infections in the acyclovir eraD W Kimberlin, C Y Lin, R F Jacobs, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Science (New York, N.Y.)|June 6, 1998
Genetic evaluation of suspected cases of transient HIV-1 infection of infantsL M Frenkel, J I Mullins, G H Learn, et al.
Pageof 6